Company: HSDTW
Filing Date: 2025-06-20
Form Type: 8-K
Source: 0001558370-25-008779
Chunk: 0

Company: Solana Co
Filing Date: 2025-06-20
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 22, 2025, the Company’s Board of Directors (the “ Board”), upon the recommendation of the Compensation Committee of the Board, adopted an amendment to the Helius Medical Technologies, Inc. 2022 Equity Incentive Plan (the “ Plan”), subject to stockholder approval, pursuant to which the aggregate number of shares of common stock that may be issued pursuant to the Plan will be increased by an amount equal to 20% of the Fully Diluted Shares (as defined in the Plan) on the 10th calendar date following the first closing of a registered offering of the Company’s common stock that occurs on or after May 15, 2025 (the “ Equity Plan Amendment”). Our stockholders approved the Equity Plan Amendment at the special stockholders meeting held on May 23, 2025. On June 16, 2025, the 10th calendar day following the closing of the Public Offering, the aggregate number of shares of common stock available to be issued pursuant to the Plan increased to 7.1 million shares.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                            HELIUS MEDICAL TECHNOLOGIES, INC.                                                        
  Dated: June 20, 2025      By:                                    /s/ Jeffrey S. Mathiesen                          
                                                                   Jeffrey S. Mathiesen                              
                                                                   Chief Financial Officer, Treasurer and Secretary